79139380 - XL-PROTEIN

Information

• Trademark
• 79139380

• Source

• Serial Number

  79139380

• Registration Number

  4634784

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 26, 2013
  11 years ago

• Registration Date

  November 11, 2014
  10 years ago

• Transaction Date

  November 21, 2023
  a year ago

• Status Date

  April 25, 2023
  a year ago

• Published for Opposition Date

  August 26, 2014
  10 years ago

• Location Date

  January 13, 2020
  5 years ago

• Status Code

  404

• Current Location

  POST REGISTRATION

  Employee Name

  MORENO, PAUL A

• Attorney Docket Number

  XLPR-02001US

  Attorney Name

  Anthony G. Craig

  Law Office Assigned Location Code

  L30

• Owners

  • XL-PROTEIN GMBH

Case File Statements

• B00001: In the statement, Class 1, 5 and 42 has been updated in accordance with the F-note dated 1/7/2020.
• GS0051: [ Pharmaceutical and veterinary preparations, preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] sanitary preparations for medical purposes; [ dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; ] preparations for destroying vermin; fungicides, herbicides [ ; pharmaceutical and diagnostic preparations for medical, dental and forensic purposes and for purposes of forensic medicine and laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, dental and forensic purposes and for purposes of forensic medicine and laboratory medicine, namely, medical and forensic diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; biomolecules (targets) for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: [ Chemical and biochemical preparations for use in research and laboratories, except for medical and veterinary use, as well as for industrial and scientific use; ] unprocessed artificial resins, unprocessed plastics
• TR0010: The word(s) "XL-protein" has no meaning in a foreign language.
• GS0421: [ Scientific and technological services and research, namely, scientific research, analysis, testing, in the field of chemistry, genetics, biology, biotechnology and biochemistry; technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the field of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; ] design and development of computer hardware [ and software; services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; design and development of programs for data processing; consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; scientific services of a technical measuring and test laboratory; technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data ]

Case File Event Statements

• 11/20/2023 - a year ago

  43 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC

• 11/20/2023 - a year ago

  42 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 7/17/2022 - 2 years ago

  41 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 5/20/2022 - 2 years ago

  40 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 5/20/2022 - 2 years ago

  39 - INVALIDATION PROCESSED Type: INPC

• 1/28/2022 - 3 years ago

  38 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 5/28/2021 - 3 years ago

  37 - CANCELLED SECTION 71 Type: C71T

• 9/23/2020 - 4 years ago

  36 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA

• 9/23/2020 - 4 years ago

  35 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 1/14/2020 - 5 years ago

  34 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME

• 1/13/2020 - 5 years ago

  33 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.

• 1/13/2020 - 5 years ago

  32 - ASSIGNED TO PARALEGAL Type: PLGL

• 11/11/2019 - 5 years ago

  31 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 8/9/2019 - 5 years ago

  30 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 7/13/2017 - 7 years ago

  29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 4/24/2015 - 9 years ago

  28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 4/2/2015 - 9 years ago

  27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/2/2015 - 9 years ago

  26 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/11/2015 - 10 years ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/11/2014 - 10 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/26/2014 - 10 years ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/26/2014 - 10 years ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/22/2014 - 10 years ago

  21 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 8/6/2014 - 10 years ago

  20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 8/6/2014 - 10 years ago

  19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 8/6/2014 - 10 years ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/18/2014 - 10 years ago

  17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/18/2014 - 10 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/26/2014 - 10 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/26/2014 - 10 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/16/2014 - 10 years ago

  13 - ASSIGNED TO LIE Type: ALIE

• 6/4/2014 - 10 years ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/4/2014 - 10 years ago

  11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/4/2014 - 10 years ago

  10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/31/2013 - 11 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/13/2013 - 11 years ago

  8 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/10/2013 - 11 years ago

  7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/10/2013 - 11 years ago

  6 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/10/2013 - 11 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/9/2013 - 11 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/9/2013 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/9/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/6/2013 - 11 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR